For further details see:
Pfizer Inc (NYSE: PFE) To Acquire Global Blood Therapeutics For $5 BillionFor further details see:
Pfizer Inc (NYSE: PFE) To Acquire Global Blood Therapeutics For $5 BillionMarket Wire News is a media platform, the information on this page was provided by Wall Street PR News via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
EMBLAVEO ® is the first β-lactam/β-lactamase inhibitor antibiotic combination approved in the European Union for treating serious infections in adult patients caused by multidrug-resistant Gram-negative bacteria, including metallo-β-lactamase-producing bacteria ...
A look at the top 10 most actives in Canada Troilus Gold Corp (TLG) rose 1.4% to $0.7 on volume of 19,342,615 shares Royal Bank of Canada (RY) fell 0.1% to $133.2 on volume of 3,932,729 shares Desjardins RI Developed ex-USA ex-Canada - Low CO2 Index ETF (DRMD) rose 0.0% to $26.72 on volum...
2024-04-18 09:15:00 ET If you had bought $1,000 worth of Pfizer (NYSE: PFE) shares five years ago, how much would that be worth today? The answer will strike you as terrific or terrible: $840. That answer will be terrible if you did buy into Pfizer then as it reflects a loss...